Resident
Yale School of Medicine
New Haven, CT, United States
Dr. Lara Kim Rotter is a physician-scientist specializing in critical care and Transplant Infectious Disease. Her academic journey began at the Technical University of Munich, where she excelled, ranking in the top 2% of her medical class and earning a prestigious scholarship from the German National Academic Foundation.
During her medical school years, Dr. Rotter developed a keen interest in molecular imaging and neurooncology. Seeking to broaden her research horizons, she joined Memorial Sloan Kettering Cancer Center in New York in 2016. This experience catalyzed her passion for research and led to a significant shift in her focus towards the immunosuppressive tumor microenvironment. She subsequently pursued this interest at the Dana-Farber Cancer Institute in Boston under the mentorship of Dr. Laurie Glimcher.
In 2022, Dr. Rotter commenced her residency in Internal Medicine at Yale, where she was accepted into the physician-scientist track in Hematology/Oncology. Her rotations in the intensive care units sparked a particular interest in Critical Care, especially in managing complex cases of infectious complications in immunocompromised hosts.
Recognizing the global impact of infectious diseases, Dr. Rotter has been awarded the Yale/Stanford Scholarship. This opportunity will allow her to gain invaluable experience in Africa, studying infectious diseases that are less common in the United States and deepening her understanding of emerging pathogens and their implications for Critical Care.
Within her residency program, Dr. Rotter has taken on active leadership roles, serving as a mentor and advocate for international medical graduates. She has also co-founded initiatives to enhance the residency experience and promote the integration of art and creativity within the medical community.
Looking ahead, Dr. Rotter aims to make significant contributions to the fields of Critical Care and Transplant Infectious Disease. Her research will focus on reestablishing immunohomeostasis in immunocompromised hosts with sepsis, reflecting her commitment to bridging the gap between Critical Care and Infectious Disease. This work addresses the unique challenges faced by a growing patient population at the intersection of these specialties.
I do not have any relevant financial / non-financial relationships with any proprietary interests.
Thursday, October 17, 2024
1:45 PM – 3:00 PM US PT